Yaron Weber
Stock Analyst at TD Cowen
(0.90)
# 3,605
Out of 4,711 analysts
8
Total ratings
25%
Success rate
-8.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Weber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Buy | $381 → $383 | $263.38 | +45.42% | 5 | Oct 21, 2024 | |
| BGNE BeiGene | Maintains: Outperform | $213 → $262 | $176.50 | +48.44% | 1 | Feb 28, 2023 | |
| NUVB Nuvation Bio | Initiates: Outperform | n/a | $2.68 | - | 1 | Mar 8, 2021 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $684 → $565 | $701.85 | -19.50% | 1 | Feb 8, 2021 |
Amgen
Oct 21, 2024
Maintains: Buy
Price Target: $381 → $383
Current: $263.38
Upside: +45.42%
BeiGene
Feb 28, 2023
Maintains: Outperform
Price Target: $213 → $262
Current: $176.50
Upside: +48.44%
Nuvation Bio
Mar 8, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.68
Upside: -
Regeneron Pharmaceuticals
Feb 8, 2021
Maintains: Outperform
Price Target: $684 → $565
Current: $701.85
Upside: -19.50%